尊龙凯时·(中国区)人生就是搏!
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Announcements and Circulars
Search
Mar 28, 2024
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Read More
Mar 18, 2024
Date of Board Meeting
Read More
Mar 15, 2024
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO APPOINTMENT OF EXECUTIVE DIRECTOR
Read More
Mar 05, 2024
Monthly Return
Read More
Feb 06, 2024
Monthly Return
Read More
Jan 05, 2024
Monthly Return
Read More
Dec 29, 2023
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Read More
Dec 29, 2023
APPOINTMENT OF EXECUTIVE DIRECTOR
Read More
Dec 21, 2023
VOLUNTARY ANNOUNCEMENT-IND APPLICATION OF 2nd GENERATION GLUCOKINASE ALLOSTERIC ACTIVATOR FILED WITH AND ACCEPTED BY FDA
Read More
Dec 13, 2023
VOLUNTARY ANNOUNCEMENT - INNOVATIVE FIRST-IN-CLASS GKA, HUATANGNING (华堂宁®) INCLUDED IN THE 2023 NATIONAL REIMBURSEMENT DRUG LIST
Read More
Dec 06, 2023
Monthly Return
Read More
Nov 22, 2023
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON RECEIPT OF THE MILESTONE PAYMENT UNDER THE COMMERCIALIZATION AGREEMENT IN RELATION TO HUATANGNING
Read More
<<
<
1
2
3
4
5
6
7
8
9
10
11
>
>>
上一页
下一页
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(华堂宁®)
Subscribe Email
Focus Us
Copyright © 2024 Hua Medicine (Shanghai) Co., Ltd. 互联网药品信息服务资格证书编号: (沪)-非经营-2022-0079
沪ICP备14036654号-1
沪公网安备 31011502013809号
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x
友情链接:
人生就是博-尊龙凯时
ag尊龙凯时·中国官方网站
pg电子官方网站
ag尊龙凯时·中国官方网站
龙8国际